| Dr Jordan Laferty, MD | |
|
303 Langdon St, Somerset, KY 42503-2750 | |
| (606) 451-5093 | |
| (606) 451-5087 |
| Full Name | Dr Jordan Laferty |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 5 Years |
| Location | 303 Langdon St, Somerset, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023570025 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 55638 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lake Cumberland Regional Hospital | Somerset, KY | Hospital |
| Lake Cumberland Regional Hospital Scu | Somerset, KY | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Apogee Medical Group Kentucky Psc | 8820164411 | 24 |
News Archive
The researchers of the Malaria Unit at Instituto de Medicina Molecular (IMM, Lisbon, Portugal) publish in the peer reviewed journal PLoS Pathogens the results of a large scale screening of more than 700 genes to identify host factors involved in the liver stage of malaria infection.
Researchers at the University of Wisconsin-Madison School of Veterinary Medicine have developed one of the first mouse models for the study of Zika virus. The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
A recent study published in The Journal of Pediatrics is the first to examine and identify a link between kidney stones in children and thickened or hardened arteries — precursors to a wide variety of cardiovascular diseases. Understanding the connection between kidney stones and cardiovascular risk factors in children may help physicians and parents implement prevention measures to reduce future risk of stroke, heart attack or other forms of vascular disease for affected children.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
› Verified 9 days ago
| Entity Name | Apogee Medical Group Kentucky Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356503114 PECOS PAC ID: 8820164411 Enrollment ID: O20080905000019 |
News Archive
The researchers of the Malaria Unit at Instituto de Medicina Molecular (IMM, Lisbon, Portugal) publish in the peer reviewed journal PLoS Pathogens the results of a large scale screening of more than 700 genes to identify host factors involved in the liver stage of malaria infection.
Researchers at the University of Wisconsin-Madison School of Veterinary Medicine have developed one of the first mouse models for the study of Zika virus. The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
A recent study published in The Journal of Pediatrics is the first to examine and identify a link between kidney stones in children and thickened or hardened arteries — precursors to a wide variety of cardiovascular diseases. Understanding the connection between kidney stones and cardiovascular risk factors in children may help physicians and parents implement prevention measures to reduce future risk of stroke, heart attack or other forms of vascular disease for affected children.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jordan Laferty, MD 114 Deck Dr, Apt A, Somerset, KY 42503 Ph: (502) 468-3093 | Dr Jordan Laferty, MD 303 Langdon St, Somerset, KY 42503-2750 Ph: (606) 451-5093 |
News Archive
The researchers of the Malaria Unit at Instituto de Medicina Molecular (IMM, Lisbon, Portugal) publish in the peer reviewed journal PLoS Pathogens the results of a large scale screening of more than 700 genes to identify host factors involved in the liver stage of malaria infection.
Researchers at the University of Wisconsin-Madison School of Veterinary Medicine have developed one of the first mouse models for the study of Zika virus. The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
A recent study published in The Journal of Pediatrics is the first to examine and identify a link between kidney stones in children and thickened or hardened arteries — precursors to a wide variety of cardiovascular diseases. Understanding the connection between kidney stones and cardiovascular risk factors in children may help physicians and parents implement prevention measures to reduce future risk of stroke, heart attack or other forms of vascular disease for affected children.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
› Verified 9 days ago
Joseph G Weigel, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Hospital Way, Suite 100, Somerset, KY 42503 Phone: 606-451-2629 Fax: 606-451-2641 | |
Dr. Harold Helton Jr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 104 Hardin Ln Ste A, Somerset, KY 42503 Phone: 606-678-2063 Fax: 606-678-2218 | |
Todd L Horn, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 56 Tower Cir, Somerset, KY 42503 Phone: 606-677-2913 Fax: 606-677-6983 | |
Abdul Rehman, Internal Medicine Medicare: Medicare Enrolled Practice Location: 305 Langdon St, Somerset, KY 42503 Phone: 606-678-3110 | |
Dr. Kathryn Terri Knutson Shufelt, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 350 Hospital Way, Somerset, KY 42503 Phone: 606-451-2600 | |
Edward Allan Grimball, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 402 Bogle St, Ste 3, Somerset, KY 42503 Phone: 606-451-9953 Fax: 606-451-1533 |